Personal information

Emails & domains

Verified email addresses

Verified email domains

Activities

Collapse all

Employment (1)

Medical College of Wisconsin: Milwaukee, WI, US

2019-07 to present | Graduate Student (Physiology)
Employment
Source: Self-asserted source
Mark Vanden Avond

Education and qualifications (2)

Northern Michigan University: Marquette, Michigan, US

2016-05 | Master of Science (Psychology)
Education
Source: Self-asserted source
Mark Vanden Avond

University of Wisconsin–Eau Claire: Eau Claire, Wisconsin, US

2014-05 | Bachelor of Science (Psychology)
Education
Source: Self-asserted source
Mark Vanden Avond

Professional activities (2)

American Heart Association: Dallas, US

2023-05 to present | Graduate Student
Membership
Source: Self-asserted source
Mark Vanden Avond

American Physiological Society: Bethesda, Maryland, US

2022 to present | Graduate Student
Membership
Source: Self-asserted source
Mark Vanden Avond

Works (7)

High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophy

Biology Open
2024-09-15 | Journal article
DOI: 10.1242/bio.060542
Contributors: Rebecca A. Slick; Jessica Sutton; Margaret Haberman; Benjamin S. O'Brien; Jennifer A. Tinklenberg; Aashay Mardikar; Mariah J. Prom; Margaret Beatka; Melanie Gartz; Mark A. Vanden Avond et al.
Source: check_circle
Crossref

Aberrations in Energetic Metabolism and Stress-Related Pathways Contribute to Pathophysiology in the Neb Conditional Knockout Mouse Model of Nemaline Myopathy

The American Journal of Pathology
2023-10 | Journal article
DOI: 10.1016/j.ajpath.2023.06.009
Contributors: Rebecca A. Slick; Jennifer A. Tinklenberg; Jessica Sutton; Liwen Zhang; Hui Meng; Margaret J. Beatka; Mark Vanden Avond; Mariah J. Prom; Emily Ott; Federica Montanaro et al.
Source: check_circle
Crossref

Different Mouse Models of Nemaline Myopathy Harboring Acta1 Mutations Display Differing Abnormalities Related to Mitochondrial Biology

The American Journal of Pathology
2023-10 | Journal article
DOI: 10.1016/j.ajpath.2023.06.008
Contributors: Jennifer A. Tinklenberg; Rebecca A. Slick; Jessica Sutton; Liwen Zhang; Hui Meng; Margaret J. Beatka; Mark Vanden Avond; Mariah J. Prom; Emily Ott; Federica Montanaro et al.
Source: check_circle
Crossref

Chronic Intermittent Sucrose Consumption Facilitates the Ability to Discriminate Opioid Receptor Blockade with Naltrexone in Rats

Nutrients
2022-02 | Journal article | Author
DOI: 10.3390/nu14050926
Contributors: David C. Jewett; Donisha S. N. K. Liyanagamage; Mark Vanden Avond; Molly A. B. Anderson; Kyleigh Twaroski; Morgan A. Marek; Kimberly F. James; Tapasya Pal; Anica Klockars; Pawel K. Olszewski et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice.

Molecular therapy. Methods & clinical development
2021-03-03 | Journal article
DOI: 10.1016/j.omtm.2021.02.024
PMID: 33850950
PMC: PMC8020351
Contributors: Shelby Hamm; Fathalikhani DD; Bukovec KE; Addington AK; Zhang H; Perry JB; McMillan RP; Lawlor MW; Prom MJ; Vanden Avond MA et al.
Source: Self-asserted source
Mark Vanden Avond

The nucleotide prodrug CERC-913 improves mtDNA content in primary hepatocytes from DGUOK-deficient rats.

Journal of inherited metabolic disease
2021-01-15 | Journal article
DOI: 10.1002/jimd.12354
PMID: 33368311
Contributors: Vanden Avond MA; Meng H; Beatka MJ; Helbling DC; Prom MJ; Sutton JL; Rebecca A Slick; Dimmock DP; Pertusati F; Serpi M et al.
Source: Self-asserted source
Mark Vanden Avond

Severe Neonatal RYR1 Myopathy With Pathological Features of Congenital Muscular Dystrophy.

Journal of neuropathology and experimental neurology
2019-03-01 | Journal article
DOI: 10.1093/jnen/nlz004
PMID: 30715496
PMC: PMC6380315
Contributors: 0000-0002-2693-5598; Mendoza D; McCarrier J; Vanden Avond MA; Harmelink MM; Barkhaus PE; Basel D; Lawlor MW
Source: Self-asserted source
Mark Vanden Avond
How many people are using ORCID?